Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Zimmer Biomet is a robotics company founded 1927, based in United States, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
Zimmer Biomet has no confirmed funding round on file and has 1 known customer, not yet tied to a specific model.
Shipped
1 known customer — no deployment yet tied to a specific model
Used by
Named in a public source that did not say which model
- Department of Veterans Affairs· United Statesusaspending.gov
Bringing together trusted expertise and innovation for better patient outcomes
Zimmer Biomet is a U.S.-based global medical technology company whose robotic surgery portfolio includes the ROSA Knee system and the enhanced ROSA Knee with OptimiZe for robotic-assisted total knee replacement. The company sells to hospitals and surgeons across the U.S. and international markets and emphasizes personalized planning, landmarking, and reproducible surgical outcomes.
Active products
1
RoboIndex
50.29
RoboScore 50.05 + Momentum 0.24
Company facts
- HQ
- Warsaw, United States
- Founded
- 1927 · 99 yrs
- Website
- www.zimmerbiomet.com
RoboScore
50.05 RoboScore + 0.24 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
On the company boards
- #30 of 39·Surgical / Medical·best robot 47.98 + depth 0.00 + news 0.24 = total 48.22
A board total ranks makers within one category. It is built from the best robot's RoboScore, a capped credit for more ranked robots, and news. It is not this company's RoboIndex above. How boards work
Milestones
Received U.S. FDA 510(k) clearance for ROSA Knee with OptimiZe, with U.S. commercial availability expected in Q1 2026.
Press coverage
In the news
1 event · last 90 days
+0.24momentumof 15 maxA new orthopedic robot is expected in 2027 as Zimmer Biomet expands its robotics salesforce
In the news
1 event · last 90 days
Why Zimmer Biomet has been in the news, across 2 outlets — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.
Public loss record
FDA
US makers file into registers that compel reporting — device adverse events to the FDA, driverless crashes to NHTSA, workplace deaths to OSHA. A maker with no record here has genuinely not had one filed against it.
A filing records that someone reported something. It is not a finding that the robot caused it, and we make no such finding.
Read every filing naming Zimmer BiometHow this record was collected, register by register
Active products by Zimmer Biomet
1 shown| # | Category | |||
|---|---|---|---|---|
| 1 |  | ROSA Knee with OptimiZe | Surgical / Medical | 48.0 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…